Skip to main content
. 2019 Apr 23;2019(4):CD013315. doi: 10.1002/14651858.CD013315

NCT01682551.

Trial name or title Evaluation of the prevention and treatment effects of Chinese medicine on high altitude illness
Methods Interventional
Participants Inclusion criteria

  1. Healthy adults


Exclusion criteria

  1. Chronic disease: cardiovascular disease, psychological disease, anaemia, migraine

  2. Long‐term use of the following materials: Chinese herbs, steroid, antibiotics

  3. Altitude acclimation: have been to mountain over 2000 metres in the past 1 month

  4. Pregnancy


Age minimum: 20 years
Age maximum: 70 years
Gender: both
Interventions

  1. Drug: acetazolamide

  2. Drug: Chinese medicine
Outcomes

  1. Risk of acute mountain sickness will be measured by the Lake Louise Self Report (Lake Louise Score = 4 with headache) (time frame: the Lake Louise Score will be measured at noon of the second day after hiking to determine the onset of AMS)

  2. Arterial oxygen saturation (time frame: arterial oxygen saturation will be measured before and after the hike)

  3. Blood pressure (time frame: blood pressure will be measured before and after the hike)

  4. Heart rate (time frame: heart rate will be measured before and after the hike)
Starting date September 2012
Contact information Not stated
Notes Not yet recruiting